{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T09:01:39Z","timestamp":1777712499119,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.ejca.2017.07.051","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T02:00:35Z","timestamp":1504836035000},"page":"59-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study"],"prefix":"10.1016","volume":"85","author":[{"given":"S.","family":"Ribero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4150-0522","authenticated-orcid":false,"given":"S.","family":"Podlipnik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9886-7694","authenticated-orcid":false,"given":"S.","family":"Osella-Abate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Sportoletti-Baduel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Manubens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Caliendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-6736","authenticated-orcid":false,"given":"M.","family":"Chavez-Bourgeois","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Cassoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Malvehy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.T.","family":"Fierro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1337-9745","authenticated-orcid":false,"given":"S.","family":"Puig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2017.07.051_bib1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","article-title":"Melanoma","volume":"355","author":"Miller","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2017.07.051_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h3074","article-title":"US melanoma prevalence has doubled over past 30\u00a0years","volume":"350","author":"McCarthy","year":"2015","journal-title":"Bmj"},{"key":"10.1016\/j.ejca.2017.07.051_bib3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/jdv.12236","article-title":"Trends in incidence and predictions of cutaneous melanoma across Europe up to 2015","volume":"28","author":"Arnold","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2017.07.051_bib4","article-title":"Analysis of trends in US melanoma incidence and mortality","author":"Glazer","year":"2016","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.soc.2014.12.012","article-title":"Long-term follow-up for melanoma patients: is there any evidence of a benefit?","volume":"24","author":"Rueth","year":"2015","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ejca.2017.07.051_bib6","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/ijcp.12393","article-title":"To what extent are current guidelines for cutaneous melanoma follow up based on scientific evidence?","volume":"68","author":"Marciano","year":"2014","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.ejca.2017.07.051_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/bjd.12687","article-title":"Comparison of melanoma guidelines in the U.S.A., Canada, Europe, Australia and New Zealand: a critical appraisal and comprehensive review","volume":"170","author":"Fong","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib8","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jaad.2016.02.1229","article-title":"Performance of diagnostic tests in an intensive follow-up protocol for patients with American Joint Committee on Cancer (AJCC) stage IIB, IIC, and III localized primary melanoma: a prospective cohort study","volume":"75","author":"Podlipnik","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib9","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1200\/JCO.2003.01.091","article-title":"Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy","volume":"21","author":"Garbe","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib10","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S1470-2045(05)70283-7","article-title":"Follow-up in patients with localised primary cutaneous melanoma","volume":"6","author":"Francken","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib11","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1245\/s10434-016-5263-7","article-title":"The MELFO-study: prospective, randomized, clinical trial for the evaluation of a stage-adjusted reduced follow-up schedule in cutaneous melanoma patients-results after 1 year","volume":"23","author":"Damude","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib12","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1245\/s10434-013-3295-9","article-title":"Intensity of follow-up after melanoma surgery","volume":"21","author":"Scally","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib13","first-page":"18","article-title":"A global review of melanoma follow-up guidelines","volume":"6","author":"Trotter","year":"2013","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jaad.2010.09.772","article-title":"Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry","volume":"66","author":"Leiter","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib15","article-title":"Patterns and timing of initial relapse in pathologic stage II melanoma patients","author":"Lee","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib16","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1111\/jdv.12413","article-title":"Analysis of clinical, dermoscopic and histopathological features of primary melanomas of patients with metastatic disease\u2013a retrospective study at the Department of Dermatology, Medical University of Graz, 2000\u20132010","volume":"28","author":"Richtig","year":"2014","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2017.07.051_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/jdv.12055","article-title":"Histopathological characteristics of subsequent melanomas in patients with multiple primary melanomas","volume":"28","author":"Vecchiato","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2017.07.051_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/path.1365","article-title":"The development of optimal pathological assessment of sentinel lymph nodes for melanoma","volume":"200","author":"Cook","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.ejca.2017.07.051_bib19","article-title":"Diagnosis and treatment of in-transit melanoma metastases","author":"Testori","year":"2016","journal-title":"Eur J Surg Oncol (EJSO)"},{"key":"10.1016\/j.ejca.2017.07.051_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/941921","article-title":"Review of diagnostic imaging modalities for the surveillance of melanoma patients","volume":"2012","author":"Xing","year":"2012","journal-title":"Dermatol Res Pract"},{"key":"10.1016\/j.ejca.2017.07.051_bib21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1470-2045(04)01609-2","article-title":"Ultrasonography or palpation for detection of melanoma nodal invasion: a meta-analysis","volume":"5","author":"Bafounta","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/jnci\/djq455","article-title":"Contemporary diagnostic imaging modalities for the staging and surveillance of melanoma patients: a meta-analysis","volume":"103","author":"Xing","year":"2011","journal-title":"JNCI J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2017.07.051_bib23","series-title":"NCCN Clinical Practice Guidelines in oncology","first-page":"1","year":"2016"},{"key":"10.1016\/j.ejca.2017.07.051_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1365-2133.2010.09883.x","article-title":"Revised U.K. guidelines for the management of cutaneous melanoma 2010","volume":"163","author":"Marsden","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib25","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jaad.2011.04.031","article-title":"Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology","volume":"65","author":"Bichakjian","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib26","unstructured":"Australian Cancer Network and New Zealand Guidelines Group. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. Available at: http:\/\/www.cancer.org.au\/content\/pdf\/HealthProfessionals\/ClinicalGuidelines\/ClinicalPracticeGuidelines-ManagementofMelanoma.pdf [last accessed 05 november 2016]. n.d."},{"key":"10.1016\/j.ejca.2017.07.051_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CMR.0b013e32833716f9","article-title":"Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit?","author":"Leiter","year":"2010","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2017.07.051_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s00432-016-2309-y","article-title":"Improvement of overall survival in stage IV melanoma patients during 2011-2014: analysis of real-world data in 441 patients of the German Central Malignant Melanoma Registry (CMMR)","volume":"143","author":"Forschner","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ejca.2017.07.051_bib29","first-page":"A440","article-title":"Improved survival in patients with advanced melanoma in real-world clinical practice: first results of the Dutch Melanoma Treatment Registry","volume":"18","author":"Leeneman","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.ejca.2017.07.051_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2017.07.051_bib31","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/1078-0432.CCR-13-3316","article-title":"Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma","volume":"21","author":"Gerami","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2017.07.051_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1067\/j.cpradiol.2009.04.001","article-title":"Cutaneous melanoma: role of ultrasound in the assessment of locoregional spread","volume":"39","author":"Catalano","year":"2010","journal-title":"Curr Probl Diagn Radiol"},{"key":"10.1016\/j.ejca.2017.07.051_bib33","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1586\/14737140.7.11.1633","article-title":"The utility of ultrasound in patients with melanoma","volume":"7","author":"Uren","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.ejca.2017.07.051_bib34","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1002\/1097-0142(20010615)91:12<2409::AID-CNCR1275>3.0.CO;2-S","article-title":"Efficacy of ultrasound B-scan compared with physical examination in follow-up of melanoma patients","volume":"91","author":"Voit","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2017.07.051_bib35","first-page":"1","article-title":"Psychological characteristics of early-stage melanoma patients: a cross-sectional study on 204 patients","author":"Tesio","year":"2017","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2017.07.051_bib36","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0959-8049(94)00333-Z","article-title":"Psychological reactions in patients with malignant melanoma","volume":"31A","author":"Brandberg","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2017.07.051_bib37","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/pon.3060","article-title":"Psychosocial aspects of post-treatment follow-up for stage I\/II melanoma: a systematic review of the literature","volume":"22","author":"Rychetnik","year":"2013","journal-title":"Psychooncology"},{"key":"10.1016\/j.ejca.2017.07.051_bib38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1468-3083.2011.04055.x","article-title":"Disease progression in melanoma patients with negative sentinel lymph node: does false-negative specimens entirely account for this phenomenon?","volume":"26","author":"Savoia","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.ejca.2017.07.051_bib39","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00259-002-1051-7","article-title":"Identification of the sentinel lymph node in patients with malignant melanoma: what are the reasons for mistakes?","volume":"30","author":"Vidal-Sicart","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.ejca.2017.07.051_bib40","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaad.2015.01.009","article-title":"Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy","volume":"72","author":"Gerami","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.ejca.2017.07.051_bib41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/CMR.0000000000000093","article-title":"Prognostic differences across sexes in melanoma patients: what has changed from the past?","volume":"24","author":"Sanlorenzo","year":"2014","journal-title":"Melanoma Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804917311991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T17:55:18Z","timestamp":1535392518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804917311991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":41,"alternative-id":["S0959804917311991"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.051","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2017.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}